Atezolizumab
ACCRU-GI-2008
Phase 2 mab active
Quick answer
Atezolizumab for Locally Advanced Hepatocellular Carcinoma is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Locally Advanced Hepatocellular Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active